Medtronic (NYSE:MDT) said today it won FDA 510(k) clearance for its TrailBlazer angled support catheter designed for use in the peripheral vascular system. The Fridley, Minn.-based company’s newly cleared TrailBlazer cath is designed to support a guide wire during peripheral artery access to enable the delivery of solutions and diagnostic agents. Support catheters, such as […]
Medtronic
Medtronic touts 1st-in-human use of Sugar.IQ with Watson ‘cognitive app’
Medtronic (NYSE:MDT) said today it launched its Sugar.IQ with Watson ‘cognitive app’ for people living with diabetes. The 1st users participating in the testing of the final release candidate will provide information about the app’s usability and function, the Fridley, Minn.-based company said. The Sugar.IQ app was developed to integrate Medtronic’s continuous glucose monitoring sensors with IBM (NYSE:IBM) Watson […]
FDA clears Medtronic’s StealthStation DBS lead placement software
Medtronic (NYSE:MDT) said today that the FDA granted 510(k) clearance for its StealthStation software, which is designed to help plan the placement of the leads used for deep-brain stimulation therapy. Fridley, Minn.-based Medtronic said StealthStation is designed to work with its O-arm imaging system to integrate pre-operative planning and intraoperative imaging during DBS device implantations. “The […]
Medtronic opens diabetes HQ in Minnesota
Medtronic (NYSE:MDT) said this month that it opened a new headquarters for its non-intensive diabetes therapy business in Plymouth, Minn. The newly opened facility will act as the global headquarters for the company’s NDT biz, as well as housing product development, research & development, marketing and operations, Fridley, Minn.-based Medtronic said. “Having our own space means […]
Medtronic escapes Infuse lawsuits involving fugitive Ohio doc
UPDATED Oct. 3, 2016, with news of Durrani’s whereabouts. Medtronic (NYSE:MDT) yesterday escaped hundreds of lawsuits filed over the allegedly off-label use of its controversial bone-growth product, Infuse, by a Cincinnati doctor who has since fled to Pakistan. Infuse consists of a collagen sponge that’s soaked in a bone-growth protein called recombinant human bone morphogenetic protein-2 […]
Medtronic touts low CD-TLR rates, strong durability in 3-year In.Pact Admiral DCB study | VIVA 2016 Roundup
Medtronic (NYSE:MDT) this week released data from 2 clinical studies evaluating its In.Pact Admiral drug-coated balloon for treating claudication and restenosis, touting sustained durability at 3-years. Results were presented at the Vascular Interventional Advances 2016 conference in Las Vegas this week. Those of you who want strength without size, lean muscles, or if you’re cutting, http://topsteroidsforsale.com is relatively safe […]
Medtronic puts $1m into National Patient Safety Foundation
The National Patient Safety Foundation’s think tank, the NPSF Lucian Leape Institute, said today it received a $1 million grant from Medtronic (NYSE:MDT) to support the institute’s goals of improving patient safety. The grant is set to be distributed over 3 years, and was announced at the Annual NPSF Lucian Leape Institute forum & keynote […]
Medtronic touts CRT study showing heightened medication adherence
Patients implanted with cardiac resynchronization devices showed a greater rate of adherence to their medication regimens after their CRT devices were put it, according to a retrospective study Medtronic (NYSE:MDT) touted today. The analysis examined data from 4,512 patients who received CRT devices between January 2008 and December 2014, evaluating adherence to recommended medications before and […]
Diabetes: Medtronic touts JAMA study of closed-loop artificial pancreas
Medtronic (NYSE:MDT) said data from a study of its closed-loop hybrid artificial pancreas, published in the Journal of the American Medical Assn., showed that the system is safe and effectively maintained blood glucose levels within range in Type I diabetes patients age 14 and older. Results from the 3-month, 124-patient trial, also presented this week at […]
Japan approves Medtronic’s Reveal Linq cardiac monitor
Medtronic (NYSE:MDT) wasted no time in launching its Reveal Linq cardiac monitor in Japan, saying it plans to launch the device there this month now that the device won approval from the Ministry of Health, Labor & Welfare. The Reveal Linq device is designed to be implanted beneath the skin on the upper left side of […]
Ablative Solutions wins FDA nod for Phase II chemical denervation trial
Ablative Solutions said today that the FDA approved a Phase II trial of its chemical denervation system for hypertension under its investigational new drug application. The trial, called Target-BP I, will evaluate the efficacy of Ablative’s Peregrine infusion ablation system, which uses ethanol to interrupt signals from sympathetic nerves in the renal artery to control […]